@prefix fhir: . @prefix owl: . @prefix rdfs: . @prefix xsd: . # - resource ------------------------------------------------------------------- a fhir:MedicinalProductDefinition; fhir:nodeRole fhir:treeRoot; fhir:Resource.id [ fhir:value "equilidem-with-ing-and-auth"]; fhir:DomainResource.text [ fhir:Narrative.status [ fhir:value "generated" ]; fhir:Narrative.div "
\n

\n \n Generated Narrative\n \n

\n

\n \n Id\n \n : equilidem-with-ing-and-auth\n

\n

\n \n Identifier\n \n : Equilidem25\n

\n

\n \n Combined Pharmaceutical Dose Form\n \n :\n \n tablet\n \n

\n

\n \n Indication\n \n : Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.\n

\n

\n \n Legal Status Of Supply\n \n :\n \n Prescription only medicine\n \n

\n

\n \n classification\n \n :\n \n B01A\n \n

\n

\n \n Ingredients\n \n :\n

\n
\n

\n \n Role\n \n :\n \n active\n \n

\n
\n

\n \n substance\n \n :\n \n Equilidonium Phosphate\n \n

\n \n \n \n \n \n \n \n \n \n
\n -\n \n \n Presentation\n \n
\n *\n \n 22 ml/1 tablet\n
\n
\n
\n
\n

\n \n Role\n \n :\n \n excipient\n \n

\n
\n

\n \n substance\n \n :\n \n Calcium Carbonate\n \n

\n \n \n \n \n \n \n \n \n \n
\n -\n \n \n Presentation\n \n
\n *\n \n 3 ml/tablet\n
\n
\n
\n

\n Names\n

\n \n \n \n \n \n \n \n \n \n
\n -\n \n \n ProductName\n \n
\n *\n \n Equilidem 2.5 mg film-coated tablets\n
\n

\n Cross References\n

\n \n \n \n \n \n \n \n \n \n
\n -\n \n \n Product\n \n
\n *\n \n Link to generic equivalent\n
\n

\n Manufacturing Business Operations\n

\n \n \n \n \n \n \n \n \n \n
\n -\n \n \n Manufacturer\n \n
\n *\n \n \n EquiliDrugCo Processing Inc.\n \n
\n
" ]; fhir:DomainResource.contained [ a fhir:Ingredient; fhir:index 0; fhir:Resource.id [ fhir:value "EquilidoniumPhosphate" ]; fhir:Ingredient.status [ fhir:value "active" ]; fhir:Ingredient.for [ fhir:index 0; fhir:Reference.reference [ fhir:value "#" ] ]; fhir:Ingredient.role [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://example.org.uk/fhir/ingredientType" ]; fhir:Coding.code [ fhir:value "active" ] ] ]; fhir:Ingredient.substance [ fhir:Ingredient.substance.code [ fhir:CodeableReference.concept [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://example.org.uk/fhir/substances" ]; fhir:Coding.code [ fhir:value "123456" ]; fhir:Coding.display [ fhir:value "Equilidonium Phosphate" ] ] ] ]; fhir:Ingredient.substance.strength [ fhir:index 0; fhir:Ingredient.substance.strength.presentationRatio [ fhir:Ratio.numerator [ fhir:Quantity.value [ fhir:value "22"^^xsd:decimal ]; fhir:Quantity.unit [ fhir:value "ml" ]; fhir:Quantity.system [ fhir:value "http://unitsofmeasure.org" ]; fhir:Quantity.code [ fhir:value "mL" ] ]; fhir:Ratio.denominator [ fhir:Quantity.value [ fhir:value "1"^^xsd:decimal ]; fhir:Quantity.unit [ fhir:value "tablet" ] ] ] ] ] ], [ a fhir:Ingredient; fhir:index 1; fhir:Resource.id [ fhir:value "CalciumCarbonate" ]; fhir:Ingredient.status [ fhir:value "active" ]; fhir:Ingredient.for [ fhir:index 0; fhir:Reference.reference [ fhir:value "#" ] ]; fhir:Ingredient.role [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://example.org.uk/fhir/ingredientType" ]; fhir:Coding.code [ fhir:value "excipient" ] ] ]; fhir:Ingredient.substance [ fhir:Ingredient.substance.code [ fhir:CodeableReference.concept [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://example.org.uk/fhir/substances" ]; fhir:Coding.code [ fhir:value "456789" ]; fhir:Coding.display [ fhir:value "Calcium Carbonate" ] ] ] ]; fhir:Ingredient.substance.strength [ fhir:index 0; fhir:Ingredient.substance.strength.presentationRatio [ fhir:Ratio.numerator [ fhir:Quantity.value [ fhir:value "3"^^xsd:decimal ]; fhir:Quantity.unit [ fhir:value "ml" ]; fhir:Quantity.system [ fhir:value "http://unitsofmeasure.org" ]; fhir:Quantity.code [ fhir:value "mL" ] ]; fhir:Ratio.denominator [ fhir:Quantity.value [ fhir:value "1"^^xsd:decimal ]; fhir:Quantity.unit [ fhir:value "tablet" ] ] ] ] ] ]; fhir:MedicinalProductDefinition.identifier [ fhir:index 0; fhir:Identifier.system [ fhir:value "http://example.org.uk/fhir/product" ]; fhir:Identifier.value [ fhir:value "Equilidem25" ] ]; fhir:MedicinalProductDefinition.combinedPharmaceuticalDoseForm [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://example.org.uk/fhir/dosefom" ]; fhir:Coding.code [ fhir:value "tablet" ] ] ]; fhir:MedicinalProductDefinition.indication [ fhir:value "Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class >= II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults."]; fhir:MedicinalProductDefinition.legalStatusOfSupply [ fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://example.org.uk/fhir/legalstatusofsupply" ]; fhir:Coding.code [ fhir:value "POM" ]; fhir:Coding.display [ fhir:value "Prescription only medicine" ] ] ]; fhir:MedicinalProductDefinition.classification [ fhir:index 0; fhir:CodeableConcept.coding [ fhir:index 0; fhir:Coding.system [ fhir:value "http://www.whocc.no/atc/example" ]; fhir:Coding.code [ fhir:value "B01A" ] ] ]; fhir:MedicinalProductDefinition.name [ fhir:index 0; fhir:MedicinalProductDefinition.name.productName [ fhir:value "Equilidem 2.5 mg film-coated tablets" ] ]; fhir:MedicinalProductDefinition.crossReference [ fhir:index 0; fhir:MedicinalProductDefinition.crossReference.product [ fhir:CodeableReference.reference [ fhir:link ; fhir:Reference.reference [ fhir:value "MedicinalProductDefinition/genericEquilidonium" ] ] ] ]; fhir:MedicinalProductDefinition.operation [ fhir:index 0; fhir:MedicinalProductDefinition.operation.organization [ fhir:index 0; fhir:Reference.display [ fhir:value "EquiliDrugCo Processing Inc." ] ] ] . a fhir:MedicinalProductDefinition . # - ontology header ------------------------------------------------------------ a owl:Ontology; owl:imports fhir:fhir.ttl; owl:versionIRI . # -------------------------------------------------------------------------------------